Rex Health Ventures
Corporate VCRaleigh · Seed–Series B · 9 people tracked
Investment thesis
Rex Health Ventures is the corporate venture arm of UNC Health, making strategic equity investments in early-stage healthcare companies and supporting portfolio companies with the expertise of UNC Health Rex and the broader UNC Health system.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directoriesWhat they invest in
from 14 of 26 portfolio companiesHealthtech ×12Biotech ×4Enterprise Software ×4Medical Devices ×4Digital Health ×3SaaS ×2AI & Machine Learning ×1Cybersecurity ×1
HQs:United States×13
Investments · 26 tracked
founders shown can be your intro pathBy year:2023 · 12020 · 12017 · 12016 · 12015 · 15 dated
Development-stage biopharmaceutical company focused on CNS biologics and small molecules.
BiotechMorrisville, US
Karen Adams(Executive Officer)Stephen E. Butts(Executive Officer)
Real-time asset tracking and workflow monitoring in healthcare
San Diego, US
Thomas Mawhinney(Director)Brandon Hull(Director)Timothy Roche(Executive Officer, Director)Terry Linn(Director)Emily Wilson(Executive Officer)Paul Wallace(Director)
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.
BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US
Vamsee Pamula(Executive Officer, Director)Richard M. West(Executive Officer, Director)Richard West
BoardDennis Sacha(Director)William A. Hawkins(Director)
BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.
Digital HealthHealthtechMedical DevicesSeattle, US
Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Gust H. Bardy(Executive Officer, Director, Promoter)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
CenTrak provides real-time location system (RTLS) software and hardware solutions for healthcare facilities, including IoT wearables, infrastructure devices, and integrations with clinical systems to manage asset tracking, patient safety, workflow optimization, and environmental monitoring.
Enterprise SoftwareHealthtechIoT
Emergo Therapeutics develops drugs designed to modulate inflammatory responses by reducing the production and secretion of inflammatory cytokines, targeting damaging symptoms across a range of diseases.
BiotechHealthtechDurham, US
Margaret Powell(Director)Robert Helmedag(Director)John E. Bailey, Jr.(Director)Moise Khayrallah(CEO)Robin Hyde-DeRuyscher(Founder)
HealthtechLos Altos, US
Mark Gonzalgo(Director)Siddarth Satish(Executive Officer, Director)Milton B. McColl(Executive Officer, Director)
BoardJay Watkins(Director)
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.
BiotechHealthtech
Bluesight provides software solutions for hospital and pharmacy operations, including inventory management, drug diversion monitoring, purchasing optimization, and compliance tools.
AI & Machine LearningEnterprise SoftwareHealthtechWashington, US
Kevin MacDonald(Executive Officer)Timothy Kress-Spatz(Executive Officer)
Early-stage biopharmaceutical company developing a novel treatment for insomnia.
Thoma Bravo is a software-focused private equity investment firm that acquires and invests in enterprise software and technology companies.
CybersecurityEnterprise SoftwareSaaS
Orlando Bravo(Founder and Managing Partner)Carl D. Thoma(Founder and Managing Partner)
symplr provides a cloud-based SaaS platform for healthcare operations, covering workforce management, provider credentialing and data management, quality analytics, compliance, and spend/contract management.
Digital HealthHealthtechSaaS
Reprieve Cardiovascular develops therapies for heart failure patients, focusing on intelligent decongestion management to accelerate fluid removal.
HealthtechMedical DevicesMilford, US
Hanson S. Gifford III(Director)Tony Fields(Executive Officer)Adam Bartnik(Executive Officer)Mark Pacyna(Executive Officer, Director)Jim Dillon(Executive Officer, Director)Gregory W Mann(Executive Officer)
HealthtechChapel Hill, US
Margaret Powell(Executive Officer, Director, Promoter)Michael Fried(Executive Officer, Director, Promoter)Moise Khayrallah(Director)
HealthtechSt. Louis, US
Scott Wrightstone(Executive Officer)Curt Hartman(Director)Maureen Oehler(Executive Officer)David Adair(Director)Jason Pesterfield(Executive Officer, Director)Ryan Denney(Executive Officer)
Portfolio news
latest coverage across their companiesLeiters · reuters.com · Oct 17, 2025
Frequently asked questions
- What stage does Rex Health Ventures invest at?
- Rex Health Ventures invests at the Seed, Series A, Series B stages.
- What is Rex Health Ventures's typical check size?
- Rex Health Ventures typically writes checks of $250K – $500K.
- What sectors does Rex Health Ventures focus on?
- Rex Health Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Rex Health Ventures located?
- Rex Health Ventures is headquartered in Raleigh, US.
Media · Podcasts & interviews
featuring the teamThe MedTech Startup Podcast - Anita Watkins - Rex Health Ventures
The MedTech Startup · Anita Watkins
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.








